- Home
- EVGN vs SBFM Comparison
EVGN vs SBFM Comparison
Compare EVGN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- SBFM
- Stock Information
- Founded
- EVGN 1999
- SBFM 2006
- Country
- EVGN Israel
- SBFM United States
- Employees
- EVGN 75
- SBFM N/A
- Industry
- EVGN Agricultural Chemicals
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- SBFM Health Care
- Exchange
- EVGN Nasdaq
- SBFM Nasdaq
- Market Cap
- EVGN 11.3M
- SBFM 7.7M
- IPO Year
- EVGN N/A
- SBFM N/A
- Fundamental
- Price
- EVGN $1.33
- SBFM $1.54
- Analyst Decision
- EVGN Strong Buy
- SBFM Strong Buy
- Analyst Count
- EVGN 1
- SBFM 1
- Target Price
- EVGN $3.50
- SBFM $15.00
- AVG Volume (30 Days)
- EVGN 5.5M
- SBFM 183.8K
- Earning Date
- EVGN 08-21-2025
- SBFM 08-15-2025
- Dividend Yield
- EVGN N/A
- SBFM N/A
- EPS Growth
- EVGN N/A
- SBFM N/A
- EPS
- EVGN N/A
- SBFM N/A
- Revenue
- EVGN $6,765,000.00
- SBFM $36,234,578.00
- Revenue This Year
- EVGN N/A
- SBFM $192.48
- Revenue Next Year
- EVGN $113.18
- SBFM N/A
- P/E Ratio
- EVGN N/A
- SBFM N/A
- Revenue Growth
- EVGN N/A
- SBFM 35.51
- 52 Week Low
- EVGN $0.95
- SBFM $1.17
- 52 Week High
- EVGN $6.80
- SBFM $7.60
- Technical
- Relative Strength Index (RSI)
- EVGN 49.73
- SBFM 53.29
- Support Level
- EVGN $1.26
- SBFM $1.42
- Resistance Level
- EVGN $1.44
- SBFM $1.75
- Average True Range (ATR)
- EVGN 0.11
- SBFM 0.12
- MACD
- EVGN -0.02
- SBFM 0.01
- Stochastic Oscillator
- EVGN 21.62
- SBFM 44.44
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.